Haplotype-resolved de novo assembly of the Vero cell line genome

Abstract The Vero cell line is the most used continuous cell line for viral vaccine manufacturing with more than 40 years of accumulated experience in the vaccine industry. Additionally, the Vero cell line has shown a high affinity for infection by MERS-CoV, SARS-CoV, and recently SARS-CoV-2, emergi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marie-Angélique Sène, Sascha Kiesslich, Haig Djambazian, Jiannis Ragoussis, Yu Xia, Amine A. Kamen
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/7132a21470654cf7a9cefa5d2162ab40
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7132a21470654cf7a9cefa5d2162ab40
record_format dspace
spelling oai:doaj.org-article:7132a21470654cf7a9cefa5d2162ab402021-12-02T16:46:32ZHaplotype-resolved de novo assembly of the Vero cell line genome10.1038/s41541-021-00358-92059-0105https://doaj.org/article/7132a21470654cf7a9cefa5d2162ab402021-08-01T00:00:00Zhttps://doi.org/10.1038/s41541-021-00358-9https://doaj.org/toc/2059-0105Abstract The Vero cell line is the most used continuous cell line for viral vaccine manufacturing with more than 40 years of accumulated experience in the vaccine industry. Additionally, the Vero cell line has shown a high affinity for infection by MERS-CoV, SARS-CoV, and recently SARS-CoV-2, emerging as an important discovery and screening tool to support the global research and development efforts in this COVID-19 pandemic. However, the lack of a reference genome for the Vero cell line has limited our understanding of host–virus interactions underlying such affinity of the Vero cell towards key emerging pathogens, and more importantly our ability to redesign high-yield vaccine production processes using Vero genome editing. In this paper, we present an annotated highly contiguous 2.9 Gb assembly of the Vero cell genome. In addition, several viral genome insertions, including Adeno-associated virus serotypes 3, 4, 7, and 8, have been identified, giving valuable insights into quality control considerations for cell-based vaccine production systems. Variant calling revealed that, in addition to interferon, chemokines, and caspases-related genes lost their functions. Surprisingly, the ACE2 gene, which was previously identified as the host cell entry receptor for SARS-CoV and SARS-CoV-2, also lost function in the Vero genome due to structural variations.Marie-Angélique SèneSascha KiesslichHaig DjambazianJiannis RagoussisYu XiaAmine A. KamenNature PortfolioarticleImmunologic diseases. AllergyRC581-607Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Vaccines, Vol 6, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Immunologic diseases. Allergy
RC581-607
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Marie-Angélique Sène
Sascha Kiesslich
Haig Djambazian
Jiannis Ragoussis
Yu Xia
Amine A. Kamen
Haplotype-resolved de novo assembly of the Vero cell line genome
description Abstract The Vero cell line is the most used continuous cell line for viral vaccine manufacturing with more than 40 years of accumulated experience in the vaccine industry. Additionally, the Vero cell line has shown a high affinity for infection by MERS-CoV, SARS-CoV, and recently SARS-CoV-2, emerging as an important discovery and screening tool to support the global research and development efforts in this COVID-19 pandemic. However, the lack of a reference genome for the Vero cell line has limited our understanding of host–virus interactions underlying such affinity of the Vero cell towards key emerging pathogens, and more importantly our ability to redesign high-yield vaccine production processes using Vero genome editing. In this paper, we present an annotated highly contiguous 2.9 Gb assembly of the Vero cell genome. In addition, several viral genome insertions, including Adeno-associated virus serotypes 3, 4, 7, and 8, have been identified, giving valuable insights into quality control considerations for cell-based vaccine production systems. Variant calling revealed that, in addition to interferon, chemokines, and caspases-related genes lost their functions. Surprisingly, the ACE2 gene, which was previously identified as the host cell entry receptor for SARS-CoV and SARS-CoV-2, also lost function in the Vero genome due to structural variations.
format article
author Marie-Angélique Sène
Sascha Kiesslich
Haig Djambazian
Jiannis Ragoussis
Yu Xia
Amine A. Kamen
author_facet Marie-Angélique Sène
Sascha Kiesslich
Haig Djambazian
Jiannis Ragoussis
Yu Xia
Amine A. Kamen
author_sort Marie-Angélique Sène
title Haplotype-resolved de novo assembly of the Vero cell line genome
title_short Haplotype-resolved de novo assembly of the Vero cell line genome
title_full Haplotype-resolved de novo assembly of the Vero cell line genome
title_fullStr Haplotype-resolved de novo assembly of the Vero cell line genome
title_full_unstemmed Haplotype-resolved de novo assembly of the Vero cell line genome
title_sort haplotype-resolved de novo assembly of the vero cell line genome
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/7132a21470654cf7a9cefa5d2162ab40
work_keys_str_mv AT marieangeliquesene haplotyperesolveddenovoassemblyoftheverocelllinegenome
AT saschakiesslich haplotyperesolveddenovoassemblyoftheverocelllinegenome
AT haigdjambazian haplotyperesolveddenovoassemblyoftheverocelllinegenome
AT jiannisragoussis haplotyperesolveddenovoassemblyoftheverocelllinegenome
AT yuxia haplotyperesolveddenovoassemblyoftheverocelllinegenome
AT amineakamen haplotyperesolveddenovoassemblyoftheverocelllinegenome
_version_ 1718383402094166016